Company Furiex Pharmaceuticals Inc
Equities
US36106P1012
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2014 | Actavis : Factbox - M&A frenzy transforming global pharma | RE |
2014 | Actavis : M&A frenzy in healthcare sector | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,816,005 | 7,922,310 ( 73.25 %) | 0 | 73.25 % |
Company contact information
Furiex Pharmaceuticals, Inc.
3900 Paramount Parkway Suite 150
27560, Morrisville
+(919) 456-7800
Sector
1st Jan change | Capi. | |
---|---|---|
+52.36% | 58.06B | |
-3.86% | 40.53B | |
+36.78% | 38.99B | |
-12.01% | 26.56B | |
+14.13% | 26.7B | |
-21.62% | 18.98B | |
+0.21% | 12.17B | |
+25.96% | 11.92B | |
+23.02% | 12B |
- Stock Market
- Equities
- Stock
- Company Furiex Pharmaceuticals Inc